News
U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive suggesting its research ...
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...
Todays focus will be on GSK Pharma shares in light of the companys announced topline growth and profitability for the full ...
The company registered standalone net profits after tax of EGP 43.559 million in Q1 2025, compared to EGP 2.046 million in net losses during Q1 2024 ...
LONDON, GREATER LONDON, UNITED KINGDOM, May 15, 2025 /EINPresswire.com/ -- What Does The Market Size Indicate About The Market Dynamics? The pemphigus vulgaris market size has grown strongly in recent ...
The move comes as GSK faces pressure to replenish its pipeline, with some of its top-selling drugs nearing the end of their ...
21hon MSN
Denmark's economic growth, which was driven by what economists described as an "exceptional surge" in pharmaceutical exports, ...
A kidnapped child, a husband with a double life, a treacherous murder plot unraveled when the police arrive at the perfect ...
Aiming to expand its hepatology portfolio, UK pharma major GSK (LSE: GSK) yesterday announced that it has entered into an ...
London: GSK plc and Boston Pharmaceuticals, a clinical stage biopharmaceutical company developing highly targeted therapies ...
14h
Zacks.com on MSNGSK Inks $2B Deal With Boston Pharmaceuticals to Buy Liver Disease DrugThrough the Boston Pharma deal, GSK aims to strengthen its pipeline, as some of its key products are nearing the end of their exclusivity period.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results